NCT02022410

Brief Summary

The purpose of the study is to prospectively evaluate patients who underwent total knee arthroplasty (TKA) using the Cumulated Ambulation Score (CAS)

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
73

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Sep 2013

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2013

Completed
16 days until next milestone

First Submitted

Initial submission to the registry

September 17, 2013

Completed
3 months until next milestone

First Posted

Study publicly available on registry

December 27, 2013

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2014

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2015

Completed
Last Updated

June 2, 2015

Status Verified

June 1, 2015

Enrollment Period

1 year

First QC Date

September 17, 2013

Last Update Submit

June 1, 2015

Conditions

CAS

Keywords

CASLength of stayRehabilitation localisationTKA

Outcome Measures

Primary Outcomes (1)

  • CAS value

    Record the CAS values for the first three operative days as mentioned in the protocol

    The 3rd day after TKA

Secondary Outcomes (1)

  • Length of stay

    between 4 days and 2 weeks

Other Outcomes (1)

  • Destination at the end of the hospitalisation

    at the moment of departure from in-hospital care

Study Arms (1)

CAS after primary and revision TKA

CAS and RAPT

Other: CAS after primary and revision TKA

Interventions

CAS after primary and revision TKAOTHER

CAS and RAPT

CAS after primary and revision TKA

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

TKA patients just after surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHUV - Hopital Orthopedique

Lausanne, Canton of Vaud, 1011, Switzerland

Location

Study Officials

  • B Jolles, Prof.

    CHUV

    STUDY DIRECTOR

  • Luis C Pereira, MSc

    CHUV

    PRINCIPAL INVESTIGATOR

  • Georgios Gkagkalis, Dr

    CHUV

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
1 Year
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prof.

Study Record Dates

First Submitted

September 17, 2013

First Posted

December 27, 2013

Study Start

September 1, 2013

Primary Completion

September 1, 2014

Study Completion

June 1, 2015

Last Updated

June 2, 2015

Record last verified: 2015-06

Locations

CH(1)